Werewolf Therapeutics, Inc. · NASDAQ:HOWL

Luke Evnin sold 141,106 Werewolf Therapeutics, Inc. shares (Form 4)

Traded May 27 to May 29, 2026 · Filed May 29, 2026

From May 27 to May 29, 2026, Luke Evnin (Director) sold 141,106 Werewolf Therapeutics, Inc. shares at an average US$0.47 for US$66,200 under a trading plan, leaving 622,579 shares. Filed May 29, 2026 (Form 4).

Sold
141,106 shares
Price
US$0.47 average (US$0.45 to US$0.48)
Value
US$66,200
Holding after
622,579 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 27, 2026Common StockSale80,852US$0.48682,833Indirect
May 28, 2026Common StockSale27,698US$0.46655,135Indirect
May 29, 2026Common StockSale32,556US$0.45622,579Indirect

Source

View original at SEC

Related